» Articles » PMID: 23295062

Association Between the GRM7 Rs3792452 Polymorphism and Attention Deficit Hyperacitiveity Disorder in a Korean Sample

Overview
Publisher Biomed Central
Date 2013 Jan 9
PMID 23295062
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to investigate the association between the ionotropic and glutamate receptors, N-methyl D-asparate 2A (GRIN2A) and 2B (GRIN2B), and the metabotropic glutamate receptor mGluR7 (GRM7) gene polymorphisms and attention-deficit hyperactivity disorder (ADHD) in Korean population.

Methods: We conducted a case-control analysis of 202 ADHD subjects and 159 controls, performed a transmission disequilibrium test (TDT) on 149 trios, and compared scores from the continuous performance test (CPT), the Children's Depression Inventory (CDI), and the State-Trait Anxiety Inventory for Children (STAIC) according to the genotype of the glutamate receptor genes.

Results: There were no significant differences in the genotype or allele frequencies of the GRIN2A rs8049651, GRIN2B rs2284411, or GRM7 rs37952452 polymorphisms between the ADHD and control groups. For 148 ADHD trios, the TDT analysis also showed no preferential transmission of the GRIN2A rs8049651 or GRIN2B rs2284411 polymorphisms. However, the TDT analysis of the GRM7 rs3792452 polymorphism showed biased transmission of the G allele (χ2 = 4.67, p = 0.031). In the ADHD probands, the subjects with GG genotype in the GRM7 rs37952452 polymorphism had higher mean T-scores for omission errors on the CPT than did those with the GA or AA genotype (t = 3.38, p = 0.001). In addition, the ADHD subjects who were homozygous for the G allele in the GRM7 rs37952452 polymorphism had higher STAIC-T (t = 5.52, p < 0.001) and STAIC-S (t = 2.74, p = 0.007) scores than did those with the GA or AA genotype.

Conclusions: These results provide preliminary evidence of an association between the GRM7 rs37952452 polymorphism and selective attention deficit and anxiety found within the Korean ADHD population.

Citing Articles

Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research.

Yates J Prog Neuropsychopharmacol Biol Psychiatry. 2024; 135:111107.

PMID: 39098647 PMC: 11409449. DOI: 10.1016/j.pnpbp.2024.111107.


Metabotropic glutamate receptor genetic variants and peripheral receptor expression affects trait scores of autistic probands.

Dutta N, Chatterjee M, Saha S, Sinha S, Mukhopadhyay K Sci Rep. 2024; 14(1):8558.

PMID: 38609494 PMC: 11014995. DOI: 10.1038/s41598-024-59290-2.


Association of glutamate receptor gene polymorphisms with attention-deficit hyperactivity disorder susceptibility: a systematic review and meta-analysis.

Zou D, Zeng Q, Liu P, Wei Y, Guo R, Zhu Y Front Genet. 2024; 15:1348387.

PMID: 38544802 PMC: 10965694. DOI: 10.3389/fgene.2024.1348387.


Novel pharmacological targets for GABAergic dysfunction in ADHD.

Ferranti A, Luessen D, Niswender C Neuropharmacology. 2024; 249:109897.

PMID: 38462041 PMC: 11843668. DOI: 10.1016/j.neuropharm.2024.109897.


Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders.

Parent H, Niswender C Mol Pharmacol. 2024; 105(5):348-358.

PMID: 38423750 PMC: 11026152. DOI: 10.1124/molpharm.124.000874.


References
1.
Riedel G, Platt B, Micheau J . Glutamate receptor function in learning and memory. Behav Brain Res. 2003; 140(1-2):1-47. DOI: 10.1016/s0166-4328(02)00272-3. View

2.
Shaffer D, Fisher P, Lucas C, Dulcan M . NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000; 39(1):28-38. DOI: 10.1097/00004583-200001000-00014. View

3.
Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E . Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature. 1995; 373(6510):151-5. DOI: 10.1038/373151a0. View

4.
MacMaster F, Carrey N, Sparkes S, Kusumakar V . Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry. 2003; 53(2):184-7. DOI: 10.1016/s0006-3223(02)01401-4. View

5.
Greenberg L, Waldman I . Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry. 1993; 34(6):1019-30. DOI: 10.1111/j.1469-7610.1993.tb01105.x. View